First-of-its-Kind Personalized ‘COVID-19 Risk Score’ Launches to Enable Safer Re-opening and Return to Work Plans

Coriell Life Sciences is rolling out a new tool in the fight against COVID-19: personalized COVID-19 Risk Scores designed to enable safer re-opening and return to work plans (especially given the recent release of the CDC guidelines for re-opening).

Read more

Precision medicine guides choice of better drug therapy in severe heart disease

Is personalized medicine cost-effective? Researchers have answered that question for one medical treatment, genotype-guided antiplatelet therapy for acute coronary syndrome patients with PCI. Their study uses pharmacogenomics and economic analysis of real-world clinical data.

Read more